Traditional drug discovery is a gamble where 90% of trials fail. But Recursion CEO Chris Gibson is using AI to shift the odds in humanity's favor. 

In this episode, Gibson explains how his Salt Lake City-based company combines massive wet-lab experiments with one of the world's most powerful supercomputers to create a "Google Maps" of human biology. 

We explore how this hybrid approach is decoding complex biological relationships to dramatically shrink the timelines and cost of bringing new medicines to market. And Chris offers us a glimpse into a future where life-saving treatments are mapped out by algorithms before they even touch a patient.

Watch our complementary documentary in which we go inside Recursion’s Salt Lake City headquarters to see how the company is using cloud computing and high-tech robotics to change the trajectory of drug discovery.